AngioDynamics, Inc. Selling and Marketing Expense
AngioDynamics, Inc. (ANGO) reported Selling and Marketing Expense of $113.40 million for the 12-month period ending 2026-05-31, per its 10-K filed 2026-07-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingAndMarketingExpense · last filed 2026-07-14
- AngioDynamics, Inc. selling and marketing expense for the quarter ending 2026-05-31 was $31.12M, a 17.73% increase year-over-year.
- AngioDynamics, Inc. selling and marketing expense for the quarter ending 2026-02-28 was $27.44M, a 7.58% increase year-over-year.
- AngioDynamics, Inc. selling and marketing expense for the quarter ending 2025-11-30 was $26.71M, a 4.38% increase year-over-year.
- AngioDynamics, Inc. selling and marketing expense for the quarter ending 2025-08-31 was $28.13M, a 9.86% increase year-over-year.
- AngioDynamics, Inc. selling and marketing expense for fiscal 2026 was $113.40M, a 9.95% increase from fiscal 2025.
- AngioDynamics, Inc. selling and marketing expense for fiscal 2025 was $103.14M, a 0.31% increase from fiscal 2024.
- AngioDynamics, Inc. selling and marketing expense for fiscal 2024 was $102.82M, a 1.37% decline from fiscal 2023.
- AngioDynamics, Inc. selling and marketing expense for fiscal 2023 was $104.25M, a 9.39% increase from fiscal 2022.
| Period end | Selling and Marketing Expense 3 month | Selling and Marketing Expense 3 month as first filed | Selling and Marketing Expense 6 month | Selling and Marketing Expense 6 month as first filed | Selling and Marketing Expense 9 month | Selling and Marketing Expense 9 month as first filed | Selling and Marketing Expense 12 month | Selling and Marketing Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-05-31 | $31.12M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $58.56M derived: sum of 2 quarters · filed 2026-07-14 | $85.27M derived: sum of 3 quarters · filed 2026-07-14 | $113.40M 10-K · filed 2026-07-14 | ||||
| 2026-02-28 | $27.44M 10-Q · filed 2026-04-02 | $54.15M derived: sum of 2 quarters · filed 2026-04-02 | $82.28M 10-Q · filed 2026-04-02 | $108.72M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-11-30 | $26.71M 10-Q · filed 2026-01-06 | $54.84M 10-Q · filed 2026-01-06 | $81.28M derived: sum of 3 quarters · filed 2026-07-14 | $106.78M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-08-31 | $28.13M 10-Q · filed 2025-10-02 | $54.57M derived: sum of 2 quarters · filed 2026-07-14 | $80.07M derived: sum of 3 quarters · filed 2026-07-14 | $105.66M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2025-05-31 | $26.44M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $51.94M derived: sum of 2 quarters · filed 2026-07-14 | $77.53M derived: sum of 3 quarters · filed 2026-07-14 | $103.14M 10-K · filed 2026-07-14 | ||||
| 2025-02-28 | $25.50M 10-Q · filed 2026-04-02 | $51.09M derived: sum of 2 quarters · filed 2026-04-02 | $76.70M 10-Q · filed 2026-04-02 | $101.28M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-11-30 | $25.59M 10-Q · filed 2026-01-06 | $51.19M 10-Q · filed 2026-01-06 | $75.78M derived: sum of 3 quarters · filed 2026-07-14 | $101.18M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-08-31 | $25.61M 10-Q · filed 2025-10-02 | $50.19M derived: sum of 2 quarters · filed 2026-07-14 | $75.59M derived: sum of 3 quarters · filed 2026-07-14 | $101.06M derived: sum of 4 quarters · filed 2026-07-14 | ||||
| 2024-05-31 | $24.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-07-14 | $49.99M derived: sum of 2 quarters · filed 2026-07-14 | $75.45M derived: sum of 3 quarters · filed 2026-07-14 | $102.82M 10-K · filed 2026-07-14 | ||||
| 2024-02-29 | $25.41M 10-Q · filed 2025-04-02 | $50.87M derived: sum of 2 quarters · filed 2025-04-02 | $78.24M 10-Q · filed 2025-04-02 | $104.53M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-11-30 | $25.46M 10-Q · filed 2025-01-08 | $52.83M 10-Q · filed 2025-01-08 | $79.13M derived: sum of 3 quarters · filed 2025-07-18 | $104.53M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-08-31 | $27.37M 10-Q · filed 2024-10-03 | $53.66M derived: sum of 2 quarters · filed 2025-07-18 | $79.07M derived: sum of 3 quarters · filed 2025-07-18 | $105.07M derived: sum of 4 quarters · filed 2025-07-18 | ||||
| 2023-05-31 | $26.29M derived: 10-K 12 month − 10-Q 9 month · filed 2025-07-18 | $51.70M derived: sum of 2 quarters · filed 2025-07-18 | $77.71M derived: sum of 3 quarters · filed 2025-07-18 | $104.25M 10-K · filed 2025-07-18 | ||||
| 2023-02-28 | $25.41M 10-Q · filed 2024-04-09 | $51.41M derived: sum of 2 quarters · filed 2024-04-09 | $77.96M 10-Q · filed 2024-04-09 | $104.79M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-11-30 | $26.01M 10-Q · filed 2024-01-08 | $52.55M 10-Q · filed 2024-01-08 | $79.38M derived: sum of 3 quarters · filed 2024-07-25 | $99.80M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-08-31 | $26.54M 10-Q · filed 2023-10-05 | $53.38M derived: sum of 2 quarters · filed 2024-07-25 | $73.79M derived: sum of 3 quarters · filed 2024-07-25 | $97.40M derived: sum of 4 quarters · filed 2024-07-25 | ||||
| 2022-05-31 | $26.83M derived: 10-K 12 month − 10-Q 9 month · filed 2024-07-25 | $47.25M derived: sum of 2 quarters · filed 2024-07-25 | $70.86M derived: sum of 3 quarters · filed 2024-07-25 | $95.30M 10-K · filed 2024-07-25 | ||||
| 2022-02-28 | $20.42M 10-Q · filed 2023-03-31 | $44.02M derived: sum of 2 quarters · filed 2023-03-31 | $68.47M 10-Q · filed 2023-03-31 | $92.29M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-11-30 | $23.61M 10-Q · filed 2023-01-06 | $48.05M 10-Q · filed 2023-01-06 | $71.87M derived: sum of 3 quarters · filed 2023-08-03 | $91.48M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-08-31 | $24.45M 10-Q · filed 2022-10-11 | $48.27M derived: sum of 2 quarters · filed 2023-08-03 | $67.87M derived: sum of 3 quarters · filed 2023-08-03 | $88.05M derived: sum of 4 quarters · filed 2023-08-03 | ||||
| 2021-05-31 | $23.82M derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-03 | $43.43M derived: sum of 2 quarters · filed 2023-08-03 | $63.60M derived: sum of 3 quarters · filed 2023-08-03 | $81.31M 10-K · filed 2023-08-03 | ||||
| 2021-02-28 | $19.61M 10-Q · filed 2022-04-07 | $39.78M derived: sum of 2 quarters · filed 2022-04-07 | $57.49M 10-Q · filed 2022-04-07 | $75.69M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-11-30 | $20.17M 10-Q · filed 2022-01-07 | $37.88M 10-Q · filed 2022-01-07 | $56.09M derived: sum of 3 quarters · filed 2022-07-22 | $77.02M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-08-31 | $17.70M 10-Q · filed 2021-09-30 | $35.91M derived: sum of 2 quarters · filed 2022-07-22 | $56.85M derived: sum of 3 quarters · filed 2022-07-22 | $76.96M derived: sum of 4 quarters · filed 2022-07-22 | ||||
| 2020-05-31 | $18.21M derived: 10-K 12 month − 10-Q 9 month · filed 2022-07-22 | $39.14M derived: sum of 2 quarters · filed 2022-07-22 | $59.25M derived: sum of 3 quarters · filed 2022-07-22 | $78.63M 10-K · filed 2022-07-22 | ||||
| 2020-02-29 | $20.93M 10-Q · filed 2021-03-31 | $41.05M derived: sum of 2 quarters · filed 2021-03-31 | $60.43M 10-Q · filed 2021-03-31 | $81.20M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-11-30 | $20.11M 10-Q · filed 2021-01-08 | $39.49M 10-Q · filed 2021-01-08 | $60.27M derived: sum of 3 quarters · filed 2021-07-27 | $78.65M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-08-31 | $19.38M 10-Q · filed 2020-10-07 | $40.16M derived: sum of 2 quarters · filed 2021-07-27 | $58.54M derived: sum of 3 quarters · filed 2021-07-27 | $77.80M derived: sum of 4 quarters · filed 2021-07-27 | ||||
| 2019-05-31 | $20.77M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-27 | $39.16M derived: sum of 2 quarters · filed 2021-07-27 | $58.42M derived: sum of 3 quarters · filed 2021-07-27 | $76.83M 10-K · filed 2021-07-27 | ||||
| 2019-02-28 | $18.39M 10-Q · filed 2020-04-08 | $19.41M 10-Q · filed 2019-04-02 | $37.65M derived: sum of 2 quarters · filed 2020-04-08 | $56.05M 10-Q · filed 2020-04-08 | $59.12M 10-Q · filed 2019-04-02 | $72.78M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-11-30 | $19.26M 10-Q · filed 2020-01-08 | $20.27M 10-Q · filed 2019-01-07 | $37.67M 10-Q · filed 2020-01-08 | $39.70M 10-Q · filed 2019-01-07 | $54.40M derived: sum of 3 quarters · filed 2020-08-10 | $72.41M derived: sum of 4 quarters · filed 2020-08-10 | ||
| 2018-08-31 | $18.41M 10-Q · filed 2019-10-04 | $19.43M 10-Q · filed 2018-10-01 | $35.14M derived: sum of 2 quarters · filed 2020-08-10 | $53.15M derived: sum of 3 quarters · filed 2020-08-10 | $72.11M derived: sum of 4 quarters · filed 2020-08-10 | |||
| 2018-05-31 | $16.73M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-10 | $34.74M derived: sum of 2 quarters · filed 2020-08-10 | $53.71M derived: sum of 3 quarters · filed 2020-08-10 | $73.11M 10-K · filed 2020-08-10 | $77.28M 10-K · filed 2018-07-23 | |||
| 2018-02-28 | $18.01M 10-Q · filed 2019-04-02 | $36.98M derived: sum of 2 quarters · filed 2019-04-02 | $56.38M 10-Q · filed 2019-04-02 | $72.90M derived: sum of 4 quarters · filed 2019-07-25 | ||||
| 2017-11-30 | $18.97M 10-Q · filed 2019-01-07 | $38.37M 10-Q · filed 2019-01-07 | $54.89M derived: sum of 3 quarters · filed 2019-07-25 | $74.31M derived: sum of 4 quarters · filed 2019-07-25 | ||||
| 2017-08-31 | $19.40M 10-Q · filed 2018-10-01 | $35.92M derived: sum of 2 quarters · filed 2019-07-25 | $55.34M derived: sum of 3 quarters · filed 2019-07-25 | $74.81M derived: sum of 4 quarters · filed 2019-07-25 | ||||
| 2017-05-31 | $16.52M derived: 10-K 12 month − 10-Q 9 month · filed 2019-07-25 | $35.94M derived: sum of 2 quarters · filed 2019-07-25 | $55.41M derived: sum of 3 quarters · filed 2019-07-25 | $74.86M 10-K · filed 2019-07-25 | $78.82M 10-K · filed 2017-08-04 | |||
| 2017-02-28 | $19.42M 10-Q · filed 2018-04-05 | $19.47M 10-Q · filed 2017-04-03 | $38.89M derived: sum of 2 quarters · filed 2018-04-05 | $58.34M 10-Q · filed 2018-04-05 | $58.48M 10-Q · filed 2017-04-03 | $78.55M derived: sum of 4 quarters · filed 2018-07-23 | ||
| 2016-11-30 | $19.47M 10-Q · filed 2018-01-05 | $19.52M 10-Q · filed 2017-01-06 | $38.92M 10-Q · filed 2018-01-05 | $39.01M 10-Q · filed 2017-01-06 | $59.13M derived: sum of 3 quarters · filed 2018-07-23 | $80.09M derived: sum of 4 quarters · filed 2018-07-23 | ||
| 2016-08-31 | $19.45M 10-Q · filed 2017-09-29 | $19.49M 10-Q · filed 2016-10-05 | $39.66M derived: sum of 2 quarters · filed 2018-07-23 | $60.62M derived: sum of 3 quarters · filed 2018-07-23 | $82.00M derived: sum of 4 quarters · filed 2018-07-23 | |||
| 2016-05-31 | $20.21M derived: 10-K 12 month − 10-Q 9 month · filed 2018-07-23 | $41.16M derived: sum of 2 quarters · filed 2018-07-23 | $62.54M derived: sum of 3 quarters · filed 2018-07-23 | $83.74M 10-K · filed 2018-07-23 | $84.72M 10-K · filed 2016-08-01 | |||
| 2016-02-29 | $20.95M 10-Q · filed 2017-04-03 | $20.30M 10-Q · filed 2016-04-11 | $42.33M derived: sum of 2 quarters · filed 2017-04-03 | $63.53M 10-Q · filed 2017-04-03 | $61.43M 10-Q · filed 2016-04-11 | $84.68M derived: sum of 4 quarters · filed 2017-04-03 | ||
| 2015-11-30 | $21.38M 10-Q · filed 2017-01-06 | $20.57M 10-Q · filed 2016-01-08 | $42.58M 10-Q · filed 2017-01-06 | $41.13M 10-Q · filed 2016-01-08 | $63.73M derived: sum of 3 quarters · filed 2017-01-06 | $83.53M derived: sum of 4 quarters · filed 2017-01-06 | ||
| 2015-08-31 | $21.20M 10-Q · filed 2016-10-05 | $20.56M 10-Q · filed 2015-10-08 | $42.35M derived: sum of 2 quarters · filed 2016-10-05 | $62.15M derived: sum of 3 quarters · filed 2016-10-05 | $83.69M derived: sum of 4 quarters · filed 2016-10-05 | |||
| 2015-05-31 | $21.15M 10-K · filed 2016-08-01 | $40.95M derived: sum of 2 quarters · filed 2016-08-01 | $62.49M derived: sum of 3 quarters · filed 2016-08-01 | $82.35M 10-K · filed 2017-08-04 | $80.62M 10-K · filed 2015-08-10 | |||
| 2015-02-28 | $19.80M 10-K · filed 2016-08-01 | $19.36M 10-Q · filed 2015-04-09 | $41.34M derived: sum of 2 quarters · filed 2016-08-01 | $62.07M 10-K · filed 2016-08-01 | $60.41M 10-Q · filed 2015-04-09 | $85.64M derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2014-11-30 | $21.54M 10-K · filed 2016-08-01 | $20.98M 10-Q · filed 2015-01-09 | $42.27M 10-K · filed 2016-08-01 | $41.05M 10-Q · filed 2015-01-09 | $65.84M derived: sum of 3 quarters · filed 2016-08-01 | $86.54M derived: sum of 4 quarters · filed 2016-08-01 | ||
| 2014-08-31 | $20.73M 10-K · filed 2016-08-01 | $20.07M 10-Q · filed 2014-10-15 | $44.30M derived: sum of 2 quarters · filed 2016-08-01 | $65.00M derived: sum of 3 quarters · filed 2016-08-01 | $86.08M derived: sum of 4 quarters · filed 2016-08-01 | |||
| 2014-05-31 | $23.57M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $44.27M derived: sum of 2 quarters · filed 2016-08-01 | $65.34M derived: sum of 3 quarters · filed 2016-08-01 | $85.31M 10-K · filed 2016-08-01 | $83.20M 10-K · filed 2014-08-14 | |||
| 2014-02-28 | $20.70M 10-Q · filed 2014-04-09 | $41.77M derived: sum of 2 quarters · filed 2015-04-09 | $61.74M 10-Q · filed 2015-04-09 | $83.57M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2013-11-30 | $21.07M 10-Q · filed 2015-01-09 | $41.04M 10-Q · filed 2015-01-09 | $62.87M derived: sum of 3 quarters · filed 2016-08-01 | $81.39M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2013-08-31 | $19.96M 10-Q · filed 2014-10-15 | $41.79M derived: sum of 2 quarters · filed 2016-08-01 | $60.31M derived: sum of 3 quarters · filed 2016-08-01 | $78.98M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2013-05-31 | $21.83M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $40.35M derived: sum of 2 quarters · filed 2016-08-01 | $59.02M derived: sum of 3 quarters · filed 2016-08-01 | $77.56M 10-K · filed 2016-08-01 | $76.12M 10-K · filed 2013-08-14 | |||
| 2013-02-28 | $18.52M 10-Q · filed 2013-04-09 | $37.19M derived: sum of 2 quarters · filed 2014-04-09 | $55.73M 10-Q · filed 2014-04-09 | $73.53M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2012-11-30 | $18.67M 10-Q · filed 2014-01-09 | $37.21M 10-Q · filed 2013-01-09 | $55.01M derived: sum of 3 quarters · filed 2016-08-01 | $70.81M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2012-08-31 | $18.54M 10-Q/A · filed 2012-11-09 | $36.34M derived: sum of 2 quarters · filed 2016-08-01 | $52.14M derived: sum of 3 quarters · filed 2016-08-01 | $67.99M derived: sum of 4 quarters · filed 2016-08-01 | ||||
| 2012-05-31 | $17.80M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $33.60M derived: sum of 2 quarters · filed 2016-08-01 | $49.45M derived: sum of 3 quarters · filed 2016-08-01 | $65.76M 10-K · filed 2016-08-01 | $64.50M 10-K · filed 2012-08-14 | |||
| 2012-02-29 | $15.80M 10-Q · filed 2013-04-09 | $31.65M derived: sum of 2 quarters · filed 2013-04-09 | $47.96M 10-Q · filed 2013-04-09 | $63.29M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-11-30 | $15.85M 10-Q · filed 2013-01-09 | $32.16M 10-Q · filed 2013-01-09 | $47.49M derived: sum of 3 quarters · filed 2013-08-14 | $62.04M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-08-31 | $16.31M 10-Q/A · filed 2012-11-09 | $31.64M derived: sum of 2 quarters · filed 2013-08-14 | $46.19M derived: sum of 3 quarters · filed 2013-08-14 | $59.99M derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2011-05-31 | $15.33M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-14 | $29.89M derived: sum of 2 quarters · filed 2013-08-14 | $43.68M derived: sum of 3 quarters · filed 2013-08-14 | $58.12M 10-K · filed 2013-08-14 | ||||
| 2011-02-28 | $14.55M 10-Q · filed 2012-04-09 | $28.35M derived: sum of 2 quarters · filed 2012-04-09 | $42.79M 10-Q · filed 2012-04-09 | |||||
| 2010-11-30 | $13.79M 10-Q · filed 2012-01-05 | $28.24M 10-Q · filed 2012-01-05 | ||||||
| 2010-08-31 | $14.44M 10-Q · filed 2011-10-11 | |||||||
| 2010-05-31 | $60.92M 10-K · filed 2012-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |